FutureGen

Company Deals

AbbVie Strikes Deal with FutureGen for Global Rights to Next-Gen TL1A Antibody FG-M701

Fineline Cube Jun 14, 2024

AbbVie (NYSE: ABBV), a biopharmaceutical giant based in the US, has announced a licensing agreement...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline